糖尿病

[ADA2015]ADA指南的HbA1c診斷標準不適用於中國青少年人群

作者:醫脈通 來源:醫脈通 日期:2015-06-12
導讀

2015年第75屆美國糖尿病協會(ADA)科學年會正在美國波士頓召開。北京朝陽醫院內分泌科高珊教授的一項研究在ADA2015年會普通壁報專場(GeneralPosterSession)上發布。該研究指出,ADA指南推薦的HbA1c診斷標準不適合診斷我國青少年人群糖尿病。

2015年第75屆美國糖尿病協會(ADA)科學年會正在美國波士頓召開。北京朝陽醫院內分泌科高珊教授的一項研究在ADA2015年會普通壁報專場(GeneralPosterSession)上發布。該研究指出,ADA指南推薦的HbA1c診斷標準不適合診斷我國青少年人群糖尿病。以下是研究摘要譯文。

背景:2010年ADA指南推薦將 HbA1c 5.7%-6.4% 定義為糖尿病前期,而 HbA1c 6.5% 是糖尿病的診斷切點。關於HbA1c診斷糖尿病前期和糖尿病標準的大型研究主要集中於成年人,青少年群體(尤其是中國青少年人群)是否適用尚屬未知。本研究旨在評估HbA1c診斷糖尿病前期和糖尿病的標準能否應用於具有糖尿病高危風險的中國青少年和年輕成人。

方法:從中國兒童及青少年代謝綜合征(BCAMS)研究中招募 559 例基線時未診斷糖尿病的個體,隨訪10年。所有人均接受口服葡萄糖耐量試驗(OGTT)和 HbA1c檢測,采用受試者特征曲線(ROC)評估HbA1c診斷標準的有效性。

結果:根據HBA1c水平對受試者進行分類:糖耐量正常者 (HBA1c<5.7%) 占85.5%,糖尿病危險者(HbA1c 5.7%-6.4%)占13.3%,糖尿病患者(HbA1c>6.5%)占1.2%。在糖尿病危險者中,有28.9%經OGTT診斷為糖尿病前期或糖尿病,而糖尿病患者中有80%為2型糖尿病患者。

2型糖尿病患者組的HbA1c診斷曲線下麵積(AUC)為0.968,最佳HbA1c診斷閾值為6.1%,特異性和靈敏度分別為99.1%和88.9%。而糖尿病前期患者組的HbA1c診斷AUC為0.683,最佳HbA1c診斷閾值為5.5%,特異性和靈敏度分別為67.4%和61.9%。

結論:ADA指南推薦的HbA1c診斷切點5.7%和6.5%不適用於診斷兒童及青少年人群的糖尿病前期和糖尿病,尤其是中國青少年人群。

研究摘要

Abstract Number: 1393-P
Title: ADA HbA1c Diagnostic Criteria Fail to Identify Prediabetes and Diabetes in a Population of Chinese Adolescents and Young Adults at High Risk for Diabetes
Authors: SHAN GAO, MING LI, XIAOXUE QU, YONGHUI WANG, XIUJUAN ZHANG, XIUJUAN ZHANG, BCAMS, STEVEN M. WILLI, Beijing, China, Philadelphia, PA
Abstract:

      Introduction: In2010, the American Diabetes Association(ADA) recommended HbA1c value of 5.7-6.4% was defined as pre-diabetes and HbA1c value of 6.5% was selected as the diagnostic cut off for diabetes.Current researches for identifying pre-diabetes and diabetes has been largely studied in adult populations, we have to think whether the criteria used for adults best serve us to make the diagnosis of diabetes or pre-diabetes in adolescents and the youths, especially in Chinese population.

      OBJECTIVE: The aim of this study was to assess HbA1c for the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at a high risk of diabetes.

      RESEARCH DESIGN AND METHODS: The study cohort consisted of 559 individuals, recruited from the cohort of Beijing Child and Adolescent Metabolic Syndrome (BCAMS) study, without a diagnosis of diabetes at baseline, with a follow-up time of 10 years. All subjects underwent an oral glucose tolerance test (OGTT) and HbA1c measurement. ROC curve analysis was performed for evaluating HbA1c screening efficacy.

      Results: Subjects were stratified according to HBA1c categories: 85.5% with normal glucose tolerance (HBA1c<5.7%), 13.3% at risk for diabetes (HBA1c 5.7-6.4%), and 1.2% with diabetes (HBA1c>6.5%). In the at risk for diabetes category, 28.9% were classified with prediabetes or diabetes, and in the diabetes category, 80 % were classified with type 2 diabetes by the OGTT. In the type 2 diabetes category, the AUC for HbA1c to diagnosed was 0.968. The optimal threshold of HbA1c was 6.1% in identifying type 2 diabetes, with a specificity of 99.1% and sensitivity of 88.9%. For pre-diabetes, the AUC for HBA1c was 0.683.The optimal threshold was 5.5%, with a specificity of 67.4% and sensitivity of 61.9%.

      The ADA suggested that an HbA1c of 5.7% and 6.5% may not serve us to make the diagnosis of diabetes or pre-diabetes in adolescents and the youths, especially in Chinese population.

分享:

相關文章

    評論

    我要跟帖
    發表
    回複 小鴨梨
    發表

    copyright©醫學論壇網 版權所有,未經許可不得複製、轉載或鏡像

    京ICP證120392號 京公網安備110105007198 京ICP備10215607號-1 (京)網藥械信息備字(2022)第00160號
    //站內統計//百度統計//穀歌統計//站長統計
    *我要反饋: 姓 名: 郵 箱: